Coccidioidomycosis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

Coccidioidomycosis, also called Valley fever, is an infection caused by the fungus Coccidioides. Symptoms include fever, cough, chest pain, chills, headache, fatigue, and joint aches. Risk factors include the weakened immune system, age, pregnancy, race, and environmental exposure. Treatment includes antifungal medications.

The Coccidioidomycosis drugs in development market research report provide comprehensive information on the therapeutics under development for Coccidioidomycosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Coccidioidomycosis and features dormant and discontinued projects.

Key Targets in the Coccidioidomycosis Pipeline Products Market

The key targets in the Coccidioidomycosis pipeline products market are Lanosterol 14 Alpha Demethylase, 1,3 Beta Glucan Synthase, Chitin Synthase, Dihydroorotate Dehydrogenase (Quinone) Mitochondrial, Ergosterol, GPI Anchored Wall Transfer Protein 1, and Smoothened Homolog.

Coccidioidomycosis Pipeline Products Analysis Market by Targets

For more target insights, download a free report sample

Key Mechanisms of Action in the Coccidioidomycosis Pipeline Products Market

The key mechanisms of action in the Coccidioidomycosis pipeline products market are Lanosterol 14 Alpha Demethylase Inhibitor, 1,3 Beta Glucan Synthase Inhibitor, Chitin Synthase Inhibitor, Dihydroorotate Dehydrogenase (Quinone) Mitochondrial Inhibitor, Ergosterol Inhibitor, GPI Anchored Wall Transfer Protein 1 Inhibitor, and Smoothened Homolog Antagonist.

Coccidioidomycosis Pipeline Products Market Analysis by Mechanism of Actions

For more mechanism of actions insights, download a free report sample

Key Routes of Administration in the Coccidioidomycosis Pipeline Products Market

The key routes of administration in the Coccidioidomycosis pipeline products market are oral, intravenous, and topical.

Coccidioidomycosis Pipeline Products Market Analysis by Routes of Administration

For more routes of administration insights, download a free report sample

Key Molecule Types in the Coccidioidomycosis Pipeline Products Market

The key molecule types in the Coccidioidomycosis pipeline products market are small molecule and vaccine.

Coccidioidomycosis Pipeline Products Market Analysis by Molecule Type

For more molecule type insights, download a free report sample

Major Companies in the Coccidioidomycosis Pipeline Products Market

Some of the major companies in the Coccidioidomycosis pipeline products market are Acea Biotech Inc, F2G Ltd, Mayne Pharma Group Ltd, Mycovia Pharmaceuticals Inc, Pfizer Inc, Scynexis Inc, and Valley Fever Solutions Inc.

Coccidioidomycosis Pipeline Products Market Analysis by Companies

To know more about major companies, download a free report sample

Market Report Overview

Scope

• The pipeline guide provides a snapshot of the global therapeutic landscape of Coccidioidomycosis (Infectious Disease).
• The pipeline guide reviews pipeline therapeutics for Coccidioidomycosis (Infectious Disease) by companies and universities/research institutes based on information derived from company and industry-specific sources.
• The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
• The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
• The pipeline guide reviews key companies involved in Coccidioidomycosis (Infectious Disease) therapeutics and enlists all their major and minor projects.
• The pipeline guide evaluates Coccidioidomycosis (Infectious Disease) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
• The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
• The pipeline guide reviews the latest news related to pipeline therapeutics for Coccidioidomycosis (Infectious Disease)

Reasons to Buy

• Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
• Recognize emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
• Find and recognize significant and varied types of therapeutics under development for Coccidioidomycosis (Infectious Disease).
• Classify potential new clients or partners in the target demographic.
• Develop tactical initiatives by understanding the focus areas of leading companies.
• Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
• Formulate corrective measures for pipeline projects by understanding Coccidioidomycosis (Infectious Disease) pipeline depth and focus of Indication therapeutics.
• Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
• Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from the pipeline.